Research, Development, or Expense

Sort each intangible-related cost into the treatment bucket that IAS 38 supports. Use phase, control, and identifiable future benefit evidence. Expense as research or prohibited internally generated asset Capitalize as development if criteria are met Capitalize as acquired identifiable intangible Discovery workshops comparing three possible product architectures Coding after technical feasibility approval with tracked payroll and expected commercial release Purchased customer contract rights in an asset acquisition Launch advertising for a newly designed brand identity Purchased patent with a legal right and measured acquisition price Final integration testing after resources, feasibility, and use plan are documented

Sign up free — one personalized lesson every day, matched to your role and goals.

Already have an account? Sign in